REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zpharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Electronic Shopping and Mail-Order Houses | All Other Nondepository Credit Intermediation | Lessors of Real Estate
Full name: Zpharma Sp. z o.o. Profile Updated: May 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Zpharma Sp. z o.o. is an enterprise located in Poland, with the main office in Krakow. The enterprise operates in the Department Stores industry. It was first established on April 21, 2017. The company’s latest financial report indicates a net sales revenue increase of 18.03% in 2023. Its total assets grew by 9.13% over the same period. In, 2023, the company’s net profit margin increased by 0.43%.

Headquarters
Ul. Gen. Henryka Kamienskiego 51
Krakow; Malopolskie; Postal Code: 30-644

Contact Details: Purchase the Zpharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Zpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Zpharma Sp. z o.o. report to view the information.
Incorporation Date:
April 21, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
18.03%▲
Total operating revenue
17.9%▲
Operating profit (EBIT)
-21.8%▼
EBITDA
-35.36%▼
Net Profit (Loss) for the Period
-10.99%▼
Total assets
9.13%▲
Total equity
-16.66%▼
Operating Profit Margin (ROS)
-0.18%▼
Net Profit Margin
0.43%▲
Return on Equity (ROE)
-0.73%▼
Debt to Equity Ratio
-12.19%▼
Quick Ratio
-0.01%▼
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo